PANGEA-HIV: phylogenetics for generalised epidemics in Africa. Lancet Infect Dis., 15(3): 259-61 (2015).

Publication Latest Publications

Title: PANGEA-HIV: phylogenetics for generalised epidemics in Africa
Authors: Pillay D, Herbeck J, Cohen MS, de Oliveira T, Fraser C, Ratmann O, Brown A-L, Kellam P, on behalf of the PANGEA-HIV Consortium.
Journal: Lancet Infect Dis.,15(3):259-61 (2015)

Journal Impact Factor (I.F.): 16.144
Number of citations (Google Scholar): 9

Abstract

The Phylogenetics and Networks for Generalized HIV Epidemics in Africa consortium (PANGEA-HIV) is an international partnership to use viral sequence analyses to assess the transmission of HIV in Africa. The aims of PANGEA-HIV include to sequence 20 000 total HIV genomes from several African study sites, with every genome sequence linked to clinical, demographic, and epidemiological data; and to direct the development of phylogenetic methods to address key challenges and opportunities in measuring, understanding, and controlling HIV transmission in generalised epidemics.

Download: Full text paper

Citation: Pillay D, Herbeck J, Cohen MS, de Oliveira T, Fraser C, Ratmann O, Brown A-L, Kellam P, on behalf of the PANGEA-HIV Consortium. PANGEA-HIV: phylogenetics for generalised epidemics in Africa Lancet Infect Dis.,15(3):259-61 (2015).


High Rates of Transmission of Drug-resistant HIV in Aruba Resulting in Reduced Susceptibility to the WHO Recommended First-line Regimen in Nearly Half of Newly Diagnosed HIV-infected Patients
Journal: Clinical Infectious Diseases (2017)

Virological Outcomes of Second-line Protease Inhibitor?Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis
Journal: Clinical Infectious Diseases (2017)

CD4+ T-cell count may not be a useful strategy to monitor antiretroviral therapy response in HTLV-1/HIV co-infected patients
Journal: Current HIV Research (2017)
All publications...


Page design updated by Tulio de Oliveira, 2013